Nef-IN-B9
CAS No. 1473404-51-1
Nef-IN-B9 ( Nef inhibitor B9 )
Catalog No. M12024 CAS No. 1473404-51-1
Nef-IN-B9 (Nef inhibitor B9) is a small molecule that blocks Nef-dependent Hck activity with IC50 of 2.8 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 170 | Get Quote |
|
5MG | 260 | Get Quote |
|
10MG | 408 | Get Quote |
|
25MG | 672 | Get Quote |
|
50MG | 945 | Get Quote |
|
100MG | 1278 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNef-IN-B9
-
NoteResearch use only, not for human use.
-
Brief DescriptionNef-IN-B9 (Nef inhibitor B9) is a small molecule that blocks Nef-dependent Hck activity with IC50 of 2.8 uM.
-
DescriptionNef-IN-B9 (Nef inhibitor B9) is a small molecule that blocks Nef-dependent Hck activity with IC50 of 2.8 uM, while the activity against Hck alone is >20 uM; also showes weak activity against other Src-family members with IC50 of >20 uM for c-Src, Lck and Lyn; blocks wild-type HIV-1 replication with IC50 of 100-300 nM, and blocks Nef-mediated SFK activation in HIV-infected cells; binds directly to Nef with Kd of 1.79 nM.
-
SynonymsNef inhibitor B9
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1473404-51-1
-
Formula Weight402.81
-
Molecular FormulaC16H11ClN6O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(E)-4-((3-chlorophenyl)diazenyl)-5-hydroxy-3-(4-nitrophenyl)-1H-pyrazole-1-carbothioamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Emert-Sedlak LA, et al. Chem Biol. 2013 Jan 24;20(1):82-91.
molnova catalog
related products
-
HMN214
HMN-214(IVX214) is a potent PLK1 inhibitor with an average IC50 of 0.12 μM.
-
Dolutegravir interme...
Dolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2.
-
BMS-818251
BMS-818251 (BMS818251) is a novel potent, small-molecule inhibitor of HIV-1 entry with EC50 of 0.019 nM against e laboratory-adapted HIV-1 strain NL4-3.